文献速递流行病学与生物统计临床试验与 GCP

撒哈拉以南非洲5国青少年女孩与成年女性妊娠期疟疾负担比较:2项临床试验的个体参与者数据二次Meta分析

Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trials.
PubMed 文献 · PLoS Med · 2022-09-02

基于贝宁、加蓬、肯尼亚、莫桑比克和坦桑尼亚2项疟疾预防临床试验中5,804名孕妇的个体参与者数据,采用两阶段Meta分析比较青少年女孩与成年女性的妊娠期疟疾结局。青少年女孩妊娠期临床疟疾(IRR 1.70,95%CI 1.20;2.39)、分娩时外周疟原虫血症(OR 2.28,95%CI 1.46;3.55)和胎盘感染(OR 1.97,95%CI 1.31;2.98)风险均高于成年女性。

要点

  • 青少年女孩妊娠期临床疟疾风险为成年女性的1.70倍(IRR 1.70,95%CI 1.20;2.39)。
  • 青少年女孩分娩时外周疟原虫血症风险为成年女性2.28倍(OR 2.28,95%CI 1.46;3.55)。
  • 青少年女孩胎盘感染风险为成年女性1.97倍(OR 1.97,95%CI 1.31;2.98)。

核心结论

  • 撒哈拉以南非洲青少年女孩较成年女性更易在妊娠期发生临床疟疾发作及分娩时外周疟原虫血症和胎盘感染。
  • 作者认为青少年女孩即使尚未怀孕也可能受益于针对性疟疾预防策略。

研究设计与样本

  • 个体参与者数据二次Meta分析,数据来自2009年至2014年贝宁、加蓬、肯尼亚、莫桑比克和坦桑尼亚2项疟疾预防临床试验的5,804名孕妇。
  • 青少年女孩1,201名,平均年龄17.5岁(SD 1.3),初产妇886名(73.8%);成年女性4,603名,平均年龄27.0岁(SD 5.4),初产妇595名(12.9%)。
  • 入组时平均孕周20.2周(SD 5.2),1,069名(18.4%)参与者HIV感染。
  • 参与者每月随访至产后访视(分娩后1个月至6周)。
  • 采用两阶段Meta分析方法,将单变量多因素回归结果合并入DerSimonian-Laird随机效应模型。

主要发现

  • 青少年女孩较成年女性妊娠期临床疟疾风险升高(IRR 1.70,95%CI 1.20;2.39,p=0.003,I²=0.0%,N=4,092)。
  • 青少年女孩较成年女性分娩时外周疟原虫血症风险升高(OR 2.28,95%CI 1.46;3.55,p<0.001,I²=0.0%,N=3,977)。
  • 青少年女孩较成年女性胎盘感染风险升高(OR 1.97,95%CI 1.31;2.98,p=0.001,I²=1.4%,N=4,797)。
  • HIV未感染亚组中,临床疟疾IRR 1.72(95%CI 1.22;2.45,p=0.002,I²=0.0%,N=3,531),外周疟原虫血症OR 2.39(95%CI 1.49;3.86,p<0.001,I²=0.0%,N=3,053),胎盘疟疾OR 1.88(95%CI 1.06至3.33,p=0.03,I²=34.9%,N=3,847)。
  • HIV感染亚组中未观察到统计学显著关联;按产次分组的亚组分析结果相似。

关键数值与推荐

  • 妊娠期临床疟疾:青少年女孩较成年女性IRR 1.70(95%CI 1.20;2.39,p=0.003,I²=0.0%,N=4,092)。
  • 分娩时外周疟原虫血症:青少年女孩较成年女性OR 2.28(95%CI 1.46;3.55,p<0.001,I²=0.0%,N=3,977)。
  • 胎盘感染:青少年女孩较成年女性OR 1.97(95%CI 1.31;2.98,p=0.001,I²=1.4%,N=4,797)。
  • HIV未感染亚组临床疟疾IRR 1.72(95%CI 1.22;2.45,p=0.002,I²=0.0%,N=3,531)。
  • HIV未感染亚组外周疟原虫血症OR 2.39(95%CI 1.49;3.86,p<0.001,I²=0.0%,N=3,053);胎盘疟疾OR 1.88(95%CI 1.06至3.33,p=0.03,I²=34.9%,N=3,847)。

临床怎么用

  • 作者认为青少年女孩即使尚未怀孕也可能受益于针对性疟疾预防策略。
  • 原文未据此给出其他临床推荐。

局限性

  • 小样本量和特定国家的结局发生率限制了部分国家纳入Meta分析。
  • 外周疟原虫血症和胎盘疟疾存在相当程度的缺失数据,分别有12.6%和18.2%的参与者这些结局缺失。
  • 鉴于临床试验的原始范围,无症状疟疾感染仅在妊娠结束时通过外周和胎盘疟原虫血症进行评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Malaria is among the top causes of death in adolescent girls (10 to 19 years) globally. Adolescent motherhood is associated with increased risk of adverse maternal and neonatal outcomes. The interaction of malaria, adolescence, and pregnancy is especially relevant in malaria endemic areas, where rates of adolescent pregnancy are high. However, data on burden of malaria among adolescent girls are limited. This study aimed at investigating whether adolescent girls were at a greater risk of experiencing malaria-related outcomes in pregnancy-parasitaemia and clinical disease-than adult women. METHODS AND FINDINGS: An individual secondary participant-level meta-analysis was conducted using data from 5,804 pregnant women participating in 2 malaria prevention clinical trials in Benin, Gabon, Kenya, Mozambique, and Tanzania between 2009 and 2014. Of the sample, 1,201 participants were adolescent girls with a mean age of 17.5 years (standard deviation (SD) 1.3) and 886 (73.8%) of them primigravidae. Among the 4,603 adult women with mean age of 27.0 years (SD 5.4), 595 (12.9%) were primigravidae. Mean gestational age at enrolment was 20.2 weeks (SD 5.2) and 1,069 (18.4%) participants were HIV-infected. Women were followed monthly until the postpartum visit (1 month to 6 weeks after delivery). This study considered outcomes including clinical episodes during pregnancy, peripheral parasitaemia at delivery, and placental malaria. A 2-stage meta-analysis approach was followed by pooling single multivariable regression results into standard DerSimonian-Laird random-effects models. Adolescent girls were more likely than adult women to present with clinical malaria during pregnancy (incidence risk ratio (IRR) 1.70, 95% confidence interval (CI) 1.20; 2.39, p-value = 0.003, I2 = 0.0%, N = 4,092), peripheral parasitaemia at delivery (odds ratio (OR) 2.28, 95% CI 1.46; 3.55, p-value < 0.001, I2 = 0.0%, N = 3,977), and placental infection (OR 1.97, 95% CI 1.31; 2.98, p-value = 0.001, I2 = 1.4%, N = 4,797). Similar associations were observed among the subgroup of HIV-uninfected participants: IRR 1.72 (95% CI 1.22; 2.45, p-value = 0.002, I2 = 0.0%, N = 3,531) for clinical malaria episodes, OR 2.39 (95% CI 1.49; 3.86, p-value < 0.001, I2 = 0.0%, N = 3,053) for peripheral parasitaemia, and OR 1.88 (95% CI 1.06 to 3.33, p-value = 0.03, I2 = 34.9%, N = 3,847) for placental malaria. Among HIV-infected subgroups statistically significant associations were not observed. Similar associations were found in the subgroup analysis by gravidity. The small sample size and outcome prevalence in specific countries limited the inclusion of some countries in the meta-analysis. Furthermore, peripheral parasitaemia and placental malaria presented a considerable level of missing data-12.6% and 18.2% of participants had missing data on those outcomes, respectively. Given the original scope of the clinical trials, asymptomatic malaria infection was only assessed at the end of pregnancy through peripheral and placental parasitaemia. CONCLUSIONS: In this study, we observed that adolescent girls in sub-Saharan Africa (SSA) are more prone to experience clinical malaria episodes during pregnancy and have peripheral malaria and placental infection at delivery than adult women. Moreover, to the best of our knowledge, for the first time this study disaggregates figures and stratifies analyses by HIV infection. Similar associations were found for both HIV-infected and uninfected women, although those for HIV-infected participants were not statistically significant. Our finding suggests that adolescent girls may benefit from targeted malaria prevention strategies even before they become pregnant.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Pons-Duran C, Mombo-Ngoma G, Macete E, et al. Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trials. PLoS Med. 2022. PMID: 36054101. doi:10.1371/journal.pmed.1004084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。